Bank Of America Corp Ligand Pharmaceuticals Inc Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 102,450 shares of LGND stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,450

Previous 149,738 31.58%

Holding current value

$12 Million

Previous $10.9 Million 21.13%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$68.53 - $87.91 $3.24 Million - $4.16 Million	-47,288 Reduced 31.58%	102,450 $8.63 Million
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $2.54 Million - $3.3 Million	37,038 Added 32.86%	149,738 $10.9 Million
Q4 2023 Feb 14, 2024	BUY	$49.57 - $72.63 $1.18 Million - $1.73 Million	23,852 Added 26.85%	112,700 $8.05 Million
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $467,311 - $533,176	6,721 Added 8.18%	88,848 $6.41 Million
Q1 2023 May 12, 2023	BUY	$65.67 - $77.08 $516,166 - $605,848	7,860 Added 10.58%	82,127 $6.04 Million
Q4 2022 Feb 10, 2023	SELL	$61.72 - $96.74 $1.46 Million - $2.28 Million	-23,591 Reduced 24.11%	74,267 $4.96 Million
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $224 - $2.42 Million	22,485 Added 29.83%	97,858 $8.43 Million
Q2 2022 Aug 12, 2022	SELL	$74.52 - $117.06 $3.64 Million - $5.71 Million	-48,793 Reduced 39.3%	75,373 $6.72 Million
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $3.7 Million - $5.9 Million	38,920 Added 45.66%	124,166 $14 Million
Q4 2021 Feb 08, 2022	BUY	$127.69 - $165.85 $953,844 - $1.24 Million	7,470 Added 9.6%	85,246 $13.2 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $430,809 - $609,313	-4,210 Reduced 5.14%	77,776 $10.8 Million
Q2 2021 Sep 13, 2021	BUY	$113.03 - $155.64 $9.27 Million - $12.8 Million	81,986 New	81,986 $10.8 Million

Others Institutions Holding LGND

# of Institutions

248

Shares Held

17.7M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.97B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Ligand Pharmaceuticals Inc Transaction History